StockNews.com Initiates Coverage on Senseonics (NYSE:SENS)

StockNews.com initiated coverage on shares of Senseonics (NYSE:SENS) in a research note issued to investors on Wednesday. The firm issued a sell rating on the stock.

Separately, HC Wainwright restated a “buy” rating and issued a $2.00 price objective on shares of Senseonics in a report on Friday, November 15th.

Senseonics Trading Down 3.2 %

Shares of NYSE SENS opened at $0.41 on Wednesday. The firm has a 50 day moving average price of $0.33 and a two-hundred day moving average price of $0.37. The stock has a market cap of $241.70 million, a P/E ratio of -3.12 and a beta of 0.77. Senseonics has a 52-week low of $0.25 and a 52-week high of $0.75. The company has a debt-to-equity ratio of 59.17, a quick ratio of 2.38 and a current ratio of 2.47.

Insider Buying and Selling

In other Senseonics news, CFO Frederick T. Sullivan purchased 124,933 shares of the firm’s stock in a transaction on Thursday, December 12th. The stock was purchased at an average cost of $0.38 per share, for a total transaction of $47,474.54. Following the acquisition, the chief financial officer now owns 2,478,844 shares in the company, valued at approximately $941,960.72. The trade was a 5.31 % increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Timothy T. Goodnow acquired 315,000 shares of the stock in a transaction dated Tuesday, December 10th. The stock was acquired at an average cost of $0.31 per share, with a total value of $97,650.00. Following the completion of the transaction, the chief executive officer now owns 11,310,355 shares in the company, valued at approximately $3,506,210.05. This represents a 2.86 % increase in their position. The disclosure for this purchase can be found here. 3.60% of the stock is owned by insiders.

Institutional Trading of Senseonics

Large investors have recently modified their holdings of the stock. Cubist Systematic Strategies LLC raised its holdings in shares of Senseonics by 25.9% during the second quarter. Cubist Systematic Strategies LLC now owns 415,404 shares of the company’s stock valued at $166,000 after purchasing an additional 85,501 shares during the period. Symmetry Partners LLC bought a new stake in Senseonics in the 3rd quarter valued at about $164,000. GSA Capital Partners LLP acquired a new position in Senseonics during the 3rd quarter worth approximately $117,000. FMR LLC lifted its stake in shares of Senseonics by 48,267.2% in the third quarter. FMR LLC now owns 168,318 shares of the company’s stock valued at $59,000 after buying an additional 167,970 shares in the last quarter. Finally, Geode Capital Management LLC increased its position in shares of Senseonics by 3.2% during the third quarter. Geode Capital Management LLC now owns 5,838,396 shares of the company’s stock worth $2,042,000 after acquiring an additional 179,103 shares in the last quarter. Institutional investors and hedge funds own 12.36% of the company’s stock.

About Senseonics

Senseonics Holdings, Inc, a medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. The company's products include Eversense, Eversense XL, and Eversense E3 that are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management.